Scientific progress in the field of cell and molecular biotechnology has led to the rapid development of biopharmaceuticals, tissue engineered applications and advanced therapy medicinal products. Against this background, the safety of these new technologies, products and applications is becoming increasingly important. An important issue in the context of risk assessment and safety is contamination with microorganisms and mycoplasmas and their detection, prevention and control using rapid and appropriate methods.

At the Alternative and Rapid Methods Conference on 26/27 November 2024 at PharmaLab, pharmacopoeial representatives and experts from industry and laboratory will present current developments in the relevant regulations and scientific methods and, in addition, experiences in the implementation and validation of alternative and rapid methods will be reported.

To find out more, please visit the PharmaLab website.